Mutation and inhibition studies of mevalonate 5-diphosphate decarboxylase.

Mevalonate 5-diphosphate decarboxylase plays an important role in regulating cholesterol biosynthesis, which was studied through incubation with various synthetic substrate analogs and characterization of mutated enzymes. The results are potentially useful for further developing inhibitors that block the mevalonate pathway which is a drug target for treating cardiovascular disease and cancer.
AuthorsYongge Qiu, Jinbo Gao, Fei Guo, Yuqin Qiao, Ding Li
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 17 Issue 22 Pg. 6164-8 (Nov 15 2007) ISSN: 0960-894X [Print] England
PMID17888661 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cholesterol
  • Carboxy-Lyases
  • pyrophosphomevalonate decarboxylase
  • Animals
  • Carboxy-Lyases (antagonists & inhibitors, chemistry, genetics)
  • Cholesterol (metabolism)
  • Drug Evaluation, Preclinical
  • Inhibitory Concentration 50
  • Kinetics
  • Liver (enzymology)
  • Molecular Structure
  • Mutagenesis, Site-Directed
  • Rats
  • Signal Transduction (drug effects)
  • Structure-Activity Relationship
  • Substrate Specificity (genetics)
  • Yeasts (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: